Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-20-000292
Filing Date
2020-11-06
Accepted
2020-11-06 13:29:14
Documents
26
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skin1104form10q.htm 10-Q 160487
2 EXHIBIT 31.1 skin1104form10qexh31_1.htm EX-31.1 8386
3 EXHIBIT 31.2 skin1104form10qexh31_2.htm EX-31.2 8405
4 EXHIBIT 32.1 skin1104form10qexh32_1.htm EX-32.1 4326
  Complete submission text file 0001554795-20-000292.txt   709748

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE skin-20200930.xml EX-101.INS 61477
6 XBRL SCHEMA FILE skin-20200930.xsd EX-101.SCH 7784
7 XBRL CALCULATION FILE skin-20200930_cal.xml EX-101.CAL 15327
8 XBRL DEFINITION FILE skin-20200930_def.xml EX-101.DEF 9522
9 XBRL LABEL FILE skin-20200930_lab.xml EX-101.LAB 71769
10 XBRL PRESENTATION FILE skin-20200930_pre.xml EX-101.PRE 51265
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 201293583
SIC: 6770 Blank Checks